Publications
- Treatment of ALK positive non-small cell lung cancer2021 | First Faculty of Medicine
- Targeted treatment of bronchogenic carcinoma2020 | First Faculty of Medicine
- Lorlatinib in the treatment of non-small cell lung cancer2020 | First Faculty of Medicine
- Effects of Treatment with Crizotinib on Non-small Cell Lung Carcinoma with ALK Translocation in the Czech Republic2018 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer2023 | Third Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Klinická onkologie2023 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
- Léčba pokročilého a metastazujícího nemalobuněčného karcinomu plic bez řídicích mutací2023 | First Faculty of Medicine
- Chest pain2022 | First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University
- Atezolizumab in the first-line treatment of non-small cell lung cancer - the IMpower110 trial2022 | First Faculty of Medicine
- Real-life Effectiveness of Afatinib Versus Gefitinib in Patients With Non-small-cell Lung Cancer: A Czech Multicentre Study2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University
Loading network view...